Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Csonka

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Endokrinologie|December 1, 1971
The effect of dehydrobenzperidol, chlorpromazine and reserpine on the pituitary-adrenal system in humanL Debreceni, I Tényi, B Csete, et al.
Clinical Physiology and Functional Imaging|May 15, 2026
Effect of device and expiratory maneuver technique on peak expiratory flow measurementsLeon L Csonka, Antti Tikkakoski, Jussi Karjalainen, et al.
Pulmonary Medicine|July 15, 2025
Relation of Changes in PEF and FEV<sub>1</sub> During Salbutamol-Induced Bronchodilation After Methacholine Challenge TestLeon L Csonka, Antti Tikkakoski, Liisa Vuotari, et al.
Clinical Physiology and Functional Imaging|June 26, 2024
Relation of changes in peak expiratory flow (PEF) and forced expiratory volume in 1 s (FEV<sub>1</sub>) during bronchoconstrictionLeon L Csonka, Antti Tikkakoski, Liisa Vuotari, et al.
European Clinical Respiratory Journal|December 19, 2025
Relation of changes in PEF and FEV<sub>1</sub> during bronchodilation in childrenLeon L Csonka, Antti Tikkakoski, Anna P Tikkakoski, et al.
Heart & Lung : the Journal of Critical Care|April 15, 2026
Regular short-acting β<sub>2</sub>-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoringLeon L Csonka, Iida Vähätalo, Pinja Ilmarinen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Endokrinologie|December 1, 1971
The effect of dehydrobenzperidol, chlorpromazine and reserpine on the pituitary-adrenal system in humanL Debreceni, I Tényi, B Csete, et al.
Clinical Physiology and Functional Imaging|May 15, 2026
Effect of device and expiratory maneuver technique on peak expiratory flow measurementsLeon L Csonka, Antti Tikkakoski, Jussi Karjalainen, et al.
Pulmonary Medicine|July 15, 2025
Relation of Changes in PEF and FEV<sub>1</sub> During Salbutamol-Induced Bronchodilation After Methacholine Challenge TestLeon L Csonka, Antti Tikkakoski, Liisa Vuotari, et al.
Clinical Physiology and Functional Imaging|June 26, 2024
Relation of changes in peak expiratory flow (PEF) and forced expiratory volume in 1 s (FEV<sub>1</sub>) during bronchoconstrictionLeon L Csonka, Antti Tikkakoski, Liisa Vuotari, et al.
European Clinical Respiratory Journal|December 19, 2025
Relation of changes in PEF and FEV<sub>1</sub> during bronchodilation in childrenLeon L Csonka, Antti Tikkakoski, Anna P Tikkakoski, et al.
Heart & Lung : the Journal of Critical Care|April 15, 2026
Regular short-acting β<sub>2</sub>-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoringLeon L Csonka, Iida Vähätalo, Pinja Ilmarinen, et al.
Pageof 2